RAPIDEXON 50ML | INJECTABLE ANTI-INFLAMMATORY

RAPIDEXON

2mg/ml SOLUTION FOR INJECTION

Steroid anti-inflammatory in injectable solution
Laboratory
FATRO IBERICA
Pharmaceutical form
Injectable solution (Sol.i.)
Composition per ml:
Active principle: Dexamethasone (as dexamethasone sodium phosphate) 2,0 mg.
Excipients: Benzyl alcohol (E-1519) 15,0 mg.
Pharmacological properties
This preparation contains dexamethasone sodium phosphate ester, a fluoromethyl derivative of
Prednisolone, which is a potent glucocorticoid with minimal mineralocorticoid activity. The
Dexamethasone has an anti-inflammatory activity between 10 and 20 times higher than that of
prednisolone. Corticosteroids reduce the immune response by inhibiting the
capillary dilation, leukocyte migration and function, and phagocytosis. The
Glucocorticoids act on metabolism by increasing gluconeogenesis.
Interactions and incompatibilities
• Simultaneous use with non-steroidal anti-inflammatory drugs may aggravate ulcers in the
digestive tube.
• Because corticosteroids can reduce the immune response to vaccines, dexamethasone is not
should be used in combination with vaccines or within two weeks of vaccination.
Indications and target species
Equine, Meat, Porcine, Dogs y Cats: Dexamethasone can be used for treatment
of inflammatory and allergic processes.
Bovine: Treatment of primary ketosis (acetonemia). Labor induction.
Equine: Treatment of arthritis, bursitis or tenosynovitis.
Although single high doses are usually well tolerated, prolonged administration may
cause serious adverse reactions, which can also occur when esters are administered
long-acting Therefore, the doses for medium to prolonged treatments should be
generally be reduced to the minimum necessary to control clinical signs.
Route of administration
• Intravenous, intramuscular, intraarticular, intrasynovial or local administration: Horses.
• Intramuscular injection: Cattle, pigs, dogs and cats.

RAPIDEXON

Posology
• Treatment of inflammatory or allergic processes: the average doses indicated are recommended.
next. However, the actual dose used should be determined based on the severity
of the signs and the time that they have been present.
Equine, Bovine, Porcine: 0,06 mg/kg of body weight, which corresponds to 1,5 ml/50 kg.
Dogs Cats: 0,1 mg/kg of body weight, which corresponds to 0,5 ml/10 kg.
Doses can be repeated once at 24-48 hour intervals if necessary. should be used
other injection sites for repeat dose administration.
• Treatment of primary ketosis in Meat (acetonemia): Recommended between 0,02 and 0,04 mg/kg
of body weight, which corresponds to 5-10 ml per cow administered by injection
intramuscularly, depending on the size of the cow and the duration of the signs. Care must be taken
to avoid overdosing in individuals of the Channel Island breed. dose will be required
greater if the signs have been present for a while or if animals that have suffered a
recurrence In most early cases, a cure will be obtained with a single dose, but
the dose can be repeated at 48 hour intervals if necessary.
• Induction of parturition: 0,04 mg/kg of body weight, which corresponds to 10 ml per cow using a
single intramuscular injection after day 270 of gestation. Delivery will usually occur in
the next 48 to 72 hours. If parturition does not occur in this period, the dose can be repeated.
• Treatment of arthritis, bursitis or tenosynovitis: By intra-articular, intrasynovial or
unique place in the horses. Dose 1ml-5ml.
Special precautions
If used for induction of parturition in cattle, an incidence may occur.
high retention of the placenta, with possible metritis and/or low fertility as a consequence.
Wait time
Meat:
– Cattle: 7 days.
– Pigs: 2 days.
– Equine: 11 days.
Milk: 72 hours.
Presentation
Vials of 25, 50 and 100 ml.
Reg No.
1957 ESP

See technical sheet

Rapidexon